Home/Filings/4/0001209191-16-127845
4//SEC Filing

Eiger BioPharmaceuticals, Inc. 4

Accession 0001209191-16-127845

CIK 0001305253operating

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 6:45 PM ET

Size

10.7 KB

Accession

0001209191-16-127845

Insider Transaction Report

Form 4
Period: 2016-06-13
Shaffer James P
Chief Business Officer
Transactions
  • Purchase

    Common Stock

    2016-06-13$22.20/sh+420$9,3242,495 total
  • Purchase

    Common Stock

    2016-06-13$22.17/sh+100$2,2172,075 total
  • Purchase

    Common Stock

    2016-06-13$22.16/sh+730$16,1771,975 total

Issuer

Eiger BioPharmaceuticals, Inc.

CIK 0001305253

Entity typeoperating

Related Parties

1
  • filerCIK 0001305253

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:45 PM ET
Size
10.7 KB